Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ruprecht

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Antiviral Therapy|April 1, 1996
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068D Mildvan, Y Bassiakos, M L Zucker, et al.
The Journal of Experimental Medicine|May 27, 2009
CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acidsIldiko Van Rhijn, David C Young, Annemieke De Jong, et al.
Plos Pathogens|November 27, 2013
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsSandeep Gupta, Johannes S Gach, Juan C Becerra, et al.
Nature Medicine|February 2, 2000
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infectionT W Baba, V Liska, R Hofmann-Lehmann, et al.
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Plos Pathogens|June 1, 2021
PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
The Journal of Infectious Diseases|March 11, 2010
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routesAgnès L Chenine, Nagadenahalli B Siddappa, Victor G Kramer, et al.
Vaccine|September 24, 2014
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virusSamir K Lakhashe, Siddappa N Byrareddy, Mingkui Zhou, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Antiviral Therapy|April 1, 1996
Synergy, activity and tolerability of zidovudine and interferon-alpha in patients with symptomatic HIV-1 infection: AIDS Clincal Trial Group 068D Mildvan, Y Bassiakos, M L Zucker, et al.
The Journal of Experimental Medicine|May 27, 2009
CD1c bypasses lysosomes to present a lipopeptide antigen with 12 amino acidsIldiko Van Rhijn, David C Young, Annemieke De Jong, et al.
Plos Pathogens|November 27, 2013
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsSandeep Gupta, Johannes S Gach, Juan C Becerra, et al.
Nature Medicine|February 2, 2000
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infectionT W Baba, V Liska, R Hofmann-Lehmann, et al.
Biomaterials|June 6, 2021
Combined PET and whole-tissue imaging of lymphatic-targeting vaccines in non-human primatesJacob T Martin, Brittany L Hartwell, Sidath C Kumarapperuma, et al.
Plos One|April 13, 2011
An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIVJennifer D Watkins, Nagadenahalli B Siddappa, Samir K Lakhashe, et al.
Plos Pathogens|June 1, 2021
PET/CT targeted tissue sampling reveals virus specific dIgA can alter the distribution and localization of HIV after rectal exposureRoslyn A Taylor, Sixia Xiao, Ann M Carias, et al.
The Journal of Infectious Diseases|March 11, 2010
Relative transmissibility of an R5 clade C simian-human immunodeficiency virus across different mucosae in macaques parallels the relative risks of sexual HIV-1 transmission in humans via different routesAgnès L Chenine, Nagadenahalli B Siddappa, Victor G Kramer, et al.
Vaccine|September 24, 2014
Multimodality vaccination against clade C SHIV: partial protection against mucosal challenges with a heterologous tier 2 virusSamir K Lakhashe, Siddappa N Byrareddy, Mingkui Zhou, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|October 20, 2001
Protection of neonatal macaques against experimental SHIV infection by human neutralizing monoclonal antibodiesR M Ruprecht, R Hofmann-Lehmann, B A Smith-Franklin, et al.
Pageof 21